0001144204-16-106812.txt : 20160603 0001144204-16-106812.hdr.sgml : 20160603 20160603170142 ACCESSION NUMBER: 0001144204-16-106812 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160602 FILED AS OF DATE: 20160603 DATE AS OF CHANGE: 20160603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ren Ken Keyong CENTRAL INDEX KEY: 0001545181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 161696508 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 v441728_4.xml OWNERSHIP DOCUMENT X0306 4 2016-06-02 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001545181 Ren Ken Keyong CASI PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE, SUITE 300 ROCKVILLE MD 20850 1 1 0 0 Chief Executive Officer Stock Options (Right to Buy) 0.8601 2016-06-02 4 A 0 280701 0 A 2016-06-02 2026-03-11 Common Stock 280701 280701 D The option grant was approved by the Board of Directors on March 11, 2016, subject to stockholder approval of amendments to the 2011 Long-Term Incentive Plan (the "Amendments"). The Company's stockholders approved the Amendments on June 2, 2016. /s/ Cynthia W. Hu, attorney-in-fact for Ken K. Ren 2016-06-03